Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

European Commission approves Lixiana

June 26, 2015

Pfizer opens enrollment in phase III trial of rivipansel in sickle cell disease

June 25, 2015

World Sickle Cell Day: LentiGlobin gene therapy continues to impress in clinical study

June 19, 2015

Sichuan Haisco discloses FXa inhibitors

June 19, 2015

PlasmaTech licenses Fanconi anemia gene therapy and CRISPR gene-editing technology

June 16, 2015

Global Blood Therapeutics reports Hb allosteric modulators

June 9, 2015

Biogen files MAA for Alprolix for hemophilia B

June 5, 2015

Stempeucel gets E.U. orphan drug designation

June 5, 2015

Chengdu Easton Pharmaceutical divulges FXa inhibitors

June 2, 2015

biOasis and partners awarded research grant focused on blood-brain barrier

May 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
In monkeys, enhanced TB vaccine dissolves after inducing protection
BioWorld Science
An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...